Regenerative medicine based on muscle-derived stem cells

Operative Techniques in Orthopaedics

Volumn 20, Issue 2, 2010, Pages 119-126

  Huard, Johnny ^a   Gharaibeh, Burhan ^a   Usas, Arvydas ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Bone; Cartilage; Muscular dystrophy; Skeletal muscle; Stem cells; Tissue engineering

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; COLLAGEN; DECORIN; FIBRIN; FIBROBLAST GROWTH FACTOR; FUMAGILLOL CHLOROACETYLCARBAMATE; GAMMA INTERFERON; LOSARTAN; POLYMER; RECOMBINANT BONE MORPHOGENETIC PROTEIN; RECOMBINANT GROWTH FACTOR; RELAXIN; SOMATOMEDIN C; SURAMIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ARTHROPLASTY; ARTICLE; ARTICULAR CARTILAGE; CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CHONDROCYTE IMPLANTATION; CHONDROPATHY; DRUG MECHANISM; DUCHENNE MUSCULAR DYSTROPHY; FRACTURE HEALING; HUMAN; HYDROGEL; MUSCLE DERIVED STEM CELL; MUSCULOSKELETAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL; STEM CELL TRANSPLANTATION; TIBIA FRACTURE; TISSUE ENGINEERING;

EID: 77953330225     PISSN: 10486666     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.oto.2009.10.013     Document Type: Article

References (90)

1. Phillippi J.A., Miller E., Weiss L., et al. Microenvironments engineered by inkjet bioprinting spatially direct adult stem cells toward muscle- and bone-like subpopulations. Stem Cells 2008, 26:127-134.
2. O'Driscoll S.W. The healing and regeneration of articular cartilage. J Bone Joint Surg Am 1998, 80:1795-1812.
3. Koval K.J. Orthopaedic Update 7 2002, American Academy of Orthopaedic Surgeons, Dallas, TX.
4. Hangody L., Kish G., Karpati Z., et al. Arthroscopic autogenous osteochondral mosaicplasty for the treatment of femoral condylar articular defects. A preliminary report. Knee Surg Sports Traumatol Arthrosc 1997, 5:262-267.
5. Easton B.T. Evaluation and treatment of the patient with osteoarthritis. J Fam Pract 2001, 50:791-797.
6. LaPrade R.F., Swiontkowski M.F. New horizons in the treatment of osteoarthritis of the knee. JAMA 1999, 281:876-878.
7. Gossec L., Dougados M. Intra-articular treatments in osteoarthritis: From the symptomatic to the structure modifying. Ann Rheum Dis 2004, 63:478-482.
8. Archibeck M.J., White R.E. What's new in adult reconstructive knee surgery. J Bone Joint Surg Am 2003, 85-A:1404-1411.
9. Giannoni P., Pagano A., Maggi E., et al. Autologous chondrocyte implantation (ACI) for aged patients: Development of the proper cell expansion conditions for possible therapeutic applications. Osteoarthritis Cartilage 2005, 13:589-600.
10. Consensus statement on total knee replacement December 8-10, 2003. J Bone Joint Surg Am 2004, 86-A:1328-1335. NIH Consensus Panel.
11. Brittberg M., Lindahl A., Nilsson A., et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994, 331:889-895.
12. Peterson L., Minas T., Brittberg M., et al.: Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: Results at two to ten years. J Bone Joint Surg Am 2003, 85-A(suppl 2):17-24.
13. Adachi N., Sato K., Usas A., et al. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol 2002, 29:1920-1930.
14. Crisan M., Yap S., Casteilla L., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
15. Kuroda R., Usas A., Kubo S., et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 2006, 54:433-442.
16. Tavian M., Zheng B., Oberlin E., et al. The vascular wall as a source of stem cells. Ann N Y Acad Sci 2005, 1044:41-50.
17. Zheng B., Cao B., Crisan M., et al. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 2007, 25:1025-1034.
18. O'Connor W.J., Botti T., Khan S.N., et al. The use of growth factors in cartilage repair. Orthop Clin North Am 2000, 31:399-410.
19. Semba I., Nonaka K., Takahashi I., et al. Positionally-dependent chondrogenesis induced by BMP4 is co-regulated by Sox9 and Msx2. Dev Dyn 2000, 217:401-414.
20. Kramer J., Hegert C., Guan K., et al. Embryonic stem cell-derived chondrogenic differentiation in vitro: Activation by BMP-2 and BMP-4. Mech Dev 2000, 92:193-205.
21. van der Kraan P.M., Buma P., van Kuppevelt T., et al. Interaction of chondrocytes, extracellular matrix and growth factors: Relevance for articular cartilage tissue engineering. Osteoarthritis Cartilage 2002, 10:631-637.
22. Sekiya I., Vuoristo J.T., Larson B.L., et al. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci USA 2002, 99:4397-4402.
23. Kubo S., Cooper G.M., Matsumoto T., et al. Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Arthritis Rheum 2009, 60:155-165.
24. Matsumoto T., Cooper G.M., Gharaibeh B., et al. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum 2009, 60:1390-1405.
25. Elisseeff J. Injectable cartilage tissue engineering. Expert Opin Biol Ther 2004, 4:1849-1859.
26. Stark Y., Suck K., Kasper C., et al. Application of collagen matrices for cartilage tissue engineering. Exp Toxicol Pathol 2006, 57:305-311.
27. Moretti M., Wendt D., Dickinson S.C., et al. Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model. Tissue Eng 2005, 11:1421-1428.
28. Li W.J., Tuli R., Okafor C., et al. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 2005, 26:599-609.
29. Caterson E.J., Nesti L.J., Li W.J., et al. Three-dimensional cartilage formation by bone marrow-derived cells seeded in polylactide/alginate amalgam. J Biomed Mater Res 2001, 57:394-403.
30. Summers B.N., Eisenstein S.M. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br 1989, 71:677-680.
31. Awad H.A., Zhang X., Reynolds D.G., et al. Recent advances in gene delivery for structural bone allografts. Tissue Eng 2007, 13:1973-1985.
32. Zhang X., Awad H.A., O'Keefe R.J., et al. A perspective: Engineering periosteum for structural bone graft healing. Clin Orthop Relat Res 2008, 466:1777-1787.
33. Urist M.R. Bone formation by autoinduction. Science 1965, 150:893-899.
34. Friedlaender G.E., Perry C.R., Cole J.D., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 2001, 83-A(suppl 1):S151-S158.
35. Burkus J.K., Gornet M.F., Dickman C.A., et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002, 15:337-349.
36. Govender S., Csimma C., Genant H.K., et al.: Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002, 84-A:2123-2134.
37. Mori S., Yoshikawa H., Hashimoto J., et al. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2. Bone 1998, 22:99-105.
38. Ferguson C., Alpern E., Miclau T., et al. Does adult fracture repair recapitulate embryonic skeletal formation?. Mech Dev 1999, 87:57-66.
39. Nakagawa M., Kaneda T., Arakawa T., et al. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 2000, 473:161-164.
40. Leung D.W., Cachianes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309.
41. Peng H., Usas A., Olshanski A., et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 2005, 20:2017-2027.
42. Peng H., Wright V., Usas A., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 2002, 110:751-759.
43. Gerber H.P., Vu T.H., Ryan A.M., et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5:623-628.
44. Street J., Bao M., deGuzman L., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002, 99:9656-9661.
45. Pelled G, Ben Arav A, Hock C, et al: Direct gene therapy for bone regeneration: Gene delivery, animal models and outcome measures. Tissue Eng Part A (Epub ahead of print).
46. Lee J.Y., Musgrave D., Pelinkovic D., et al. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 2001, 83-A:1032-1039.
47. Lee J.Y., Qu-Petersen Z., Cao B., et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000, 150:1085-1100.
48. Shen H.C., Peng H., Usas A., et al. Ex vivo gene therapy-induced endochondral bone formation: Comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. Bone 2004, 34:982-992.
49. Shen H.C., Peng H., Usas A., et al. Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. J Gene Med 2004, 6:984-991.
50. Peng H., Usas A., Gearhart B., et al. Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation. Mol Ther 2004, 9:885-894.
51. Lee J.Y., Peng H., Usas A., et al. Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Hum Gene Ther 2002, 13:1201-1211.
52. Musgrave D.S., Pruchnic R., Bosch P., et al. Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. J Bone Joint Surg Br 2002, 84:120-127.
53. Peng H., Usas A., Gearhart B., et al. Converse relationship between in vitro osteogenic differentiation and in vivo bone healing elicited by different populations of muscle-derived cells genetically engineered to express BMP4. J Bone Miner Res 2004, 19:630-641.
54. Peng H., Usas A., Hannallah D., et al. Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4. Mol Ther 2005, 12:239-246.
55. Wright V., Peng H., Usas A., et al. BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther 2002, 6:169-178.
56. Corsi K.A., Pollett J.B., Phillippi J.A., et al. Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex. J Bone Miner Res 2007, 22:1592-1602.
57. Li Y., Foster W., Deasy B.M., et al. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: A key event in muscle fibrogenesis. Am J Pathol 2004, 164:1007-1019.
58. Li Y., Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 2002, 161:895-907.
59. Fukushima K., Badlani N., Usas A., et al. The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 2001, 29:394-402.
60. Chan Y.S., Li Y., Foster W., et al. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med 2005, 33:43-51.
61. Chan Y.S., Li Y., Foster W., et al. Antifibrotic effects of suramin in injured skeletal muscle after laceration. J Appl Physiol 2003, 95:771-780.
62. Sato K., Li Y., Foster W., et al. Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle Nerve 2003, 28:365-372.
63. Foster W., Li Y., Usas A., et al. Gamma interferon as an antifibrosis agent in skeletal muscle. J Orthop Res 2003, 21:798-804.
64. Negishi S., Li Y., Usas A., et al. The effect of relaxin treatment on skeletal muscle injuries. Am J Sports Med 2005, 33:1816-1824.
65. Bedair H.S., Karthikeyan T., Quintero A., et al. Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle. Am J Sports Med 2008, 36:1548-1554.
66. Li Y., Li J., Zhu J., et al. Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol Ther 2007, 15:1616-1622.
67. Li Z.B., Kollias H.D., Wagner K.R. Myostatin directly regulates skeletal muscle fibrosis. J Biol Chem 2008, 283:19371-19378.
68. Nozaki M., Li Y., Zhu J., et al. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am J Sports Med 2008, 36:2354-2362.
69. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
70. Watkins S.C., Hoffman E.P., Slayter H.S., et al. Immunoelectron microscopic localization of dystrophin in myofibres. Nature 1988, 333:863-866.
71. Arahata K., Ishiura S., Ishiguro T., et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 1988, 333:861-863.
72. Bonilla E., Samitt C.E., Miranda A.F., et al. Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface. Cell 1988, 54:447-452.
73. Zubrzycka-Gaarn E.E., Bulman D.E., Karpati G., et al. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 1988, 333:466-469.
74. Ervasti J.M., Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991, 66:1121-1131.
75. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., et al. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992, 355:696-702.
76. Huard J., Roy R., Bouchard J.P., et al. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc 1992, 24:3049-3051.
77. Huard J., Roy R., Guerette B., et al. Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection. Muscle Nerve 1994, 17:224-234.
78. Qu-Petersen Z., Deasy B., Jankowski R., et al. Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration. J Cell Biol 2002, 157:851-864.
79. Beauchamp J.R., Morgan J.E., Pagel C.N., et al. Quantitative studies of efficacy of myoblast transplantation. Muscle Nerve 1994, 18(suppl):261.
80. Fan Y., Maley M., Beilharz M., et al. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 1996, 19:853-860.
81. Mendell J.R., Kissel J.T., Amato A.A., et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 1995, 333:832-838.
82. Gussoni E., Blau H.M., Kunkel L.M. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 1997, 3:970-977.
83. Gharaibeh B., Lu A., Tebbets J., et al. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc 2008, 3:1501-1509.
84. Bischoff R. The satellite cell and muscle regeneration. Myology: Basic and Clinical 1994, 97-118. McGraw-Hill, New York, NY. A.G. Engel, C. Franzini-Armstrong (Eds.).
85. Asakura A., Komaki M., Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001, 68:245-253.
86. Collins C.A., Olsen I., Zammit P.S., et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005, 122:289-301.
87. Rando T.A. The adult muscle stem cell comes of age. Nat Med 2005, 11:829-831.
88. Zammit P., Beauchamp J. The skeletal muscle satellite cell: Stem cell or son of stem cell?. Differentiation 2001, 68:193-204.
89. Sherwood R.I., Christensen J.L., Conboy I.M., et al. Isolation of adult mouse myogenic progenitors: Functional heterogeneity of cells within and engrafting skeletal muscle. Cell 2004, 119:543-554.
90. Oshima H., Payne T.R., Urish K.L., et al. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 2005, 12:1130-1141.